Jacksonville, FL – Memorial Hospital is proud to be the first hospital in Northeast Florida to offer patients Aquablation® therapy, a minimally invasive technique to treat benign prostatic hyperplasia (BPH), the non-cancerous enlargement of the prostate. The procedure uses ultrasound mapping along with a robotically controlled waterjet to remove prostate tissue.
“This procedure is revolutionizing the way we treat prostate conditions,” said Urologist Ali Kasraeian, MD. “Unlike traditional surgical treatments, the Aquablation therapy combines high-tech surgical equipment with real-time ultrasound, allowing the surgeon to map the treatment plan and precisely target the tissue resection area, while sparing surrounding tissue.”
Aquablation therapy is delivered by the AquaBeam System, the world’s first commercially available autonomous tissue removal robot for the treatment of BPH. Aquablation therapy combines multi-dimensional imaging and robotics to deliver a heat-free waterjet to remove the enlarged prostate tissue with less risk of side effects than the surgical gold-standard TURP.
Aquablation therapy is performed in the operating room, while the patient is either under spinal or general anesthesia. First, the urologist will use multi-dimensional imaging to identify the exact treatment plan based on the patient’s specific anatomy. Next, the AquaBeam System robot executes the treatment plan, removing the excess prostate tissue with a heat-free waterjet, eliminating the possibility of complications arising from thermal injury. The procedure takes less than an hour, and typically involves an overnight stay.
“Bringing the AquaBeam system to Memorial reaffirms the hospital’s commitment to offering the community the most advanced minimally-invasive techniques to help patients recover faster and get back to their lives quicker,” said Memorial Hospital President & CEO Bradley S. Talbert, FACHE. “By offering this innovative procedure, we are able to give men suffering from prostate conditions another safe and effective treatment option.”
Benign Prostatic Hyperplasia (BPH) is the non-cancerous enlargement of the prostate, a common condition affecting one out of every two men over the age of 50, and up to 90% of men older than 80. As the prostate grows, it can constrict the urethra and cause bothersome urinary symptoms, including a frequent or urgent need to urinate. Untreated, BPH can block the flow of urine out of the bladder and cause bladder, urinary tract or kidney problems.
Memorial is the first hospital in the region to offer Aquablation therapy. The hospital began performing the procedure this week.